次世代エネルギー産業・グリーン経済の国際リサーチ情報サイト

医療ロボットがもたらす医療変革:価格設定・コストメリット評価、購買行動分析

Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle

出版元:MarketsandMarkets(米国)LinkIcon出版元について
発行年:2016年 4月
定価 Single User License(1名様ライセンス)US$5,650(米国ドル)/Multi User License(5名様)$6,650 /Corporate User License $8,150
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算(お見積り日TTSレート)となります。
納品形態:PDF by Email
当調査レポートは英文 97ページになります。
商品コード:MAM334

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。



【レポート紹介】
Medical robots are increasingly being adopted by hospitals and patients across the globe, particularly in the U.S. Demographic change, shortage of healthcare professionals, need to improve quality of life for the disabled and elderly, and need to improve surgical procedures coupled with the focus to develop technologically advanced robots are some of the factors expected to stimulate growth the adoption of medical robots.

This report provides qualitative assessment of medical robots (surgical/rehabilitation/non-invasive radiosurgery/hospital & pharmacy) in terms of prices of different types of robots, price variation by application & geography, reimbursements of medical robots, buying cycle, financing options available to the end-users to access the technology, price wars among market players, marketing & promotional strategies focused by the vendors, and cost-benefit assessment based on research studies and expert opinions.

The application and technology form the two important components that guide the final pricing of a medical robot. For instance, the surgical robots for laparoscopic applications are most expensive as compared to surgical robots for other applications. In addition, technological variation further creates price variation, an example for which is the named Zeno R25 (rehabilitation robot by RoboKind) which is expected to be launched in retail space at a price tag of USD 2,700. To cut the cost in R25, the manufacturers reduced the number of motors below the waist from 12 to three while still allowing the robot to walk and turn.

Medical Robotics being a highly sophisticated technology showcases slow adoption due to economic hurdles. However, medical robots have become an extremely popular topic over the last few years. Thus, the cost-benefit assessment has taken center stage in the industry and is dominating almost every conversation and headlining several conferences in the field of robotics. The report has provided cost-benefit assessment covering cost benefit studies and industry opinion. The section provides a guideline to the stakeholders in understanding the investment structure and the cost-savings achieved through the use of each type of robot. To increase the access to this expensive technology, manufacturers have been offering varied financing options to the healthcare providers. Some of the options include leasing, pay-per-use, bundled payments, rental agreements, and expanded payment terms, among others.

【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

英文詳細目次(table of contents)

【原文詳細目次】

Medical Robots Transforming Healthcare: Pricing & Cost-Benefit Assessment (Price Variation (by Product (Surgical Robots, Rehabilitation Robotics, Stereotactic Radiosurgery), by Application, by Geography), Reimbursement, Selection Criteria, Buying Cycle

Table of Contents

1 INTRODUCTION
2 MEDICAL ROBOTS: PRICING LANDSCAPE

2.1 INTRODUCTION
2.2 INDICATIVE PRICE LIST
2.2.1 SURGICAL ROBOTS
2.2.2 REHABILITATION ROBOTS
2.2.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
2.2.4 HOSPITAL & PHARMACY ROBOTS
2.3 PRICE VARIATION ASSESSMENT
2.3.1 BY APPLICATION
2.3.2.1 Surgical Robots
2.3.2.2 Rehabilitation Robots
2.3.2.3 Non-invasive Radiosurgery Systems (Robot-based)
2.3.2.4 Hospital & Pharmacy Robots
2.3.2 BY GEOGRAPHY
2.3.1.1 Surgical Robots
2.3.1.2 Rehabilitation Robots
2.3.1.3 Hospital & Pharmacy Robots
2.3.1.4 Non-invasive Radiosurgery Systems (Robot-based)

3 EXPECTED PRICE WAR: SURGICAL ROBOTS MARKET (INTUITIVE VS. COMPETITION)
4 MEDICAL ROBOTS: REIMBURSEMENT LANDSCAPE, BY REGION

4.1 SURGICAL ROBOTS
4.2 REHABILITATION ROBOTS
4.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)

5 MEDICAL ROBOTS: MAJOR PRICE DETERMINANTS
6 MEDICAL ROBOTS: FINANCING OPTIONS ASSESSMENT

6.1 SURGICAL ROBOTS
6.2 REHABILITATION ROBOTS
6.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
6.4 HOSPITAL & PHARMACY ROBOTS

7 MEDICAL ROBOTS: KEY INFLUNCERS & DECISION-MAKERS

7.1 SURGICAL ROBOTS
7.2 REHABILITATION ROBOTS
7.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
7.4 HOSPITAL & PHARMACY ROBOTS

8 MEDICAL ROBOTS: KEY SELECTION CRITERIA FOR END-USER

8.1 SURGICAL ROBOTS
8.2 REHABILITATION ROBOTS
8.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
8.4 HOSPITAL & PHARMACY ROBOTS

9 MEDICAL ROBOTS: BUYING CYCLE ASSESSMENT
10 MEDICAL ROBOTS: MARKETING & PROMOTIONS STRATEGIES ADOPTED BY VENDORS

10.1 SURGICAL ROBOTS
10.2 REHABILITATION ROBOTS
10.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
10.4 HOSPITAL & PHARMACY ROBOTS

11 COST-BENEFIT ASSESSMENT (BASED ON RESEARCH STUDIES & EXPERT OPINIONS)

11.1 SURGICAL ROBOTS
11.1.1 COST-BENEFIT STUDIES
11.1.1.1 A da vinci robot system can make sensefor a mature laparoscopic prostatectomy program
11.1.1.2 Robot-assisted surgery compared with open surgery and laparascopic surgery: clinical effectiveness and economic analyses
11.1.2 INDUSTRY SPEAKS
11.2 REHABILITATION ROBOTS
11.2.1 ECONOMIC IMPACT OF REHABILITATION ROBOTS VIS-À-VIS DISEASE BURDEN
11.2.2 COST-BENEFIT STUDIES
11.2.2.1 An economic analysis of robot-assisted therapy fro long-term upper-limb imparement after stroke
11.2.3 INDUSTRY SPEAKS
11.3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED)
11.3.1 COST-BENEFIT STUDIES
11.3.1.1 A comparative study of Gamma Knife radiosurgery versus open surgery for intracranial pathology
11.3.1.2 Outcomes and cost-effectiveness of gamma knife radiosurgery and whole-brain radiotherapy for multiple metastatic brain tumors
11.3.1.3 Cost-effectiveness analysis of a randomized study comparing radiosurgery with radiosurgery and whole brain radition therapy in patients with 1 to 3 brain metastases
11.3.1.4 Cyberknife for prostrate cancer: Is it cost-effective
11.3.1.5 TomoTherapy, Gamma Knife, and Cyberknife Therapies for Patients with Tumors of the Lung, Central Nervous System, or Intra-abdomen: A Systematic Review of Clinical Effectiveness and Cost-effectiveness
11.3.2 INDUSTRY SPEAKS
11.4 HOSPITAL & PHARMACY ROBOTS
11.4.1 COST-BENEFIT STUDIES
11.4.1.1 Impact of Robotic Dispensing Machines in german Pharmacies on Business Performance Indicators
11.4.1.2 Recent Trends in the Usage of Robotics in Pharmacy
11.4.1.3 Cover Story - Rise of Machines
11.4.1.4 Automated Medication Dispensing Systems : A Review of the Clinical Benefits, Harms, and Cost-effectiveness
11.4.2 INDUSTRY SPEAKS

12 APPENDIX

12.1 INDICATIVE LIST OF RESEARCH STUDIES HIGHLIGHTED ON COMPANY WEBSITES
12.1.1 INTUTIVE SURGICALS
12.1.2 MAZOR ROBOTICS
12.1.3 VARIAN MEDICAL SYSTEMS
12.1.4 ELEKTA AB
12.1.5 HOCOMA AG
12.1.6 REWALK
12.2 SOURCES: INDICATIVE LIST OF RESEARCH STUDIES HIGHLIGHTED ON COMPANY WEBSITES

LIST OF TABLES

TABLE 1 SURGICAL ROBOTS: INDICATIVE PRICE LIST
TABLE 2 REHABILITATION ROBOTS: INDICATIVE PRICE LIST
TABLE 3 NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOTIC-BASED): INDICATIVE PRICE LIST
TABLE 4 HOSPITAL & PHARMACY ROBOTS: INDICATIVE PRICE LIST
TABLE 5 SURGICAL ROBOTS: PRICE VARIATION, BY APPLICATION
TABLE 6 VARIOUS SPECIFICATIONS FOR DA VINCI XI, SI, AND SI-E
TABLE 7 PRICE VARIATIONS FOR NON-INVASIVE RADIOSURGERY SYSTEMS (ROBOT-BASED), BY BRAND
TABLE 8 PRICE VARIATIONS FOR SURGICAL ROBOTS, BY GEOGRAPHY
TABLE 9 PRICE VARIATIONS FOR REHABILITATION ROBOTS, BY GEOGRAPHY
TABLE 10 PRICE VARIATIONS FOR HOSPITAL & PHARMACY ROBOTS, BY GEOGRAPHY
TABLE 11 CYBERKNIFE INSTALLATION, BY REGION
TABLE 12 GAMMA KNIFE INSTALLATION, BY REGION
TABLE 13 APPROXIMATE CYBERKNIFE & GAMMA KNIFE PROCEDURE COST, BY REGION
TABLE 14 SURGICAL ROBOTS: PRICE WAR COMPETITION ANALYSIS
TABLE 15 REIMBURSEMENT DETAILS: CHANGES IN TOTAL GLOBAL PAYMENT FOR SINGLE SESSION EXTRACRANIAL AND MULTISESSION SRS (STEREOTACTIC RADIOSURGERY)/SBRT (STEREOTACTIC BODY RADIATION THERAPY)
TABLE 16 AVERAGE AND INCREMENTAL PER-PATIENT COSTS OF ROBOT ASSISTED RADICAL PROSTATECTOMY (RARP), OPEN RADICAL PROSTATECTOMY (ORP), AND LAPAROSCOPIC RADICAL PROSTATECTOMY (LRP)
TABLE 17 UNDISCOUNTED PER CENTER COSTS OF DA VINCI ROBOT, MAINTENANCE, CONSUMABLES, AND TRAINING, BY YEAR
TABLE 18 SHARE OF ROAD TRAFFIC INURIES MORTALITY IN LEADING CAUSE OF DEATHS WORLD-WIDE 2004
TABLE 19 SHARE OF ROAD TRAFFIC INURIES MORTALITY IN LEADING CAUSE OF DEATHS WORLD-WIDE 2030
TABLE 20 HOURLY REHABILITATION ROBOT COST
TABLE 21 HOURLY PHYSIOTHERAPIST COST
TABLE 22 HOURLY ROBOT-AIDED THERAPY COST (INCLUDING PHYSIOTHERAPIST COST)
TABLE 23 COMPARISON OF ROBOT-ASSISTED REAHBILITATION THERAPY AND CONVENTIONAL THERAPY
TABLE 24 A COMPARISON OF AVERAGE 12 MONTH COSTS OF TREATING PATIENTS WITH OPEN AND GAMMA KNIFE RADIOSURGERY (GKRS)
TABLE 25 A COMPARISON OF GAMMA KNIFE RADIOSURGERY (GKRS) AND WHOLE BRAIN RADIOTHERAPY (WBRT)
TABLE 26 A COMPARISON OF ‘STEREOTACTIC RADIOSURGERY (SRS)+ OBSERVATION’ AND ‘SRS + WHOLE BRAIN RADIATION THERAPY (WBRT)’
TABLE 27 A COMPARISON OF TOTAL LIFETIME COSTS OF SURGERY, CYBERKNIFE (CK), INTENSITY MODULATED RADIATION THERAPY (IMRT), AND PROTON THERAPY (PT)
TABLE 28 A COMPARISON OF BASE CASE AVERAGE CAPITAL EQUIPMENT COSTS PER PATIENT FOR GAMMA KNIFE (GK), CYBERKNIFE (CK), AND OTHER LINAC SYSTEMS
TABLE 29 SAMPLE CALCULATION OF THE TOTAL COSTS OF A ROBOTIC DISPENSING MACHINE
TABLE 30 COMPARISON OF ROWA VMAX, GO.COMPACT, ROBOPHARMA, AND CONSIS
TABLE 31 RELATIVE RISK REDUCTION (RRR) OR RELATIVE RISK INCREASE (RRI) COMPARISON OF AUTOMATED DISPENSING DEVICES (ADD) IN DIFFERENT SET-UPS
TABLE 32 FIVE-YEAR DRUG DISTRIBUTION COSTS OF AUTOMATED DISPENSING DEVICES (ADD)
TABLE 33 ACCURACY RATES BEFORE AND AFTER IMPLEMENTATION OF A CAROUSEL DISPENSING TECHNOLOGY (CDT)

LIST OF FIGURES

FIGURE 1 MEDICAL ROBOTS: A HISTORICAL TIMELINE
FIGURE 2 MEDICAL ROBOTS, BY PRODUCT SEGMENTATION
FIGURE 3 FACTORS RESPONSIBLE FOR PRICE VARIATION IN MEDICAL ROBOTS
FIGURE 4 SURGICAL ROBOTS: PRICE VARIATION, BY APPLICATION
FIGURE 5 PRICE VARIATIONS FOR LAPAROSCOPY ROBOTS, BY BRAND
FIGURE 6 PRICE VARIATIONS FOR DA VINCI ROBOTS, BY TYPE
FIGURE 7 PRICE VARIATIONS FOR STEERABLE ROBOTIC CATHETER SYSTEMS, BY BRAND
FIGURE 8 PRICE VARIATIONS FOR NEUROLOGY ROBOTS, BY BRAND
FIGURE 9 PRICE VARIATIONS FOR ORTHOPEDIC ROBOTS, BY BRAND
FIGURE 10 PRICE VARIATIONS FOR REHABILITATION ROBOTS, BY TYPE & BRAND
FIGURE 11 MEDICAL ROBOTS: MAJOR PRICE DETERMINANTS
FIGURE 12 MEDICAL ROBOTS: FINANCING OPTIONS ASSESSMENT, BY TYPE
FIGURE 13 MEDICAL ROBOTS: KEY STAKEHOLDERS IN PURCHASE DECISION, BY TYPE
FIGURE 14 MEDICAL ROBOTS: KEY INFLUNCERS & DECISION-MAKERS
FIGURE 15 MEDICAL ROBOTS: KEY SELECTION CRITERIA FOR END-USER, BY TYPE
FIGURE 16 MEDICAL ROBOTS: BUYING CYCLE ASSESSMENT, BY TYPE
FIGURE 17 MEDICAL ROBOTS: MARKETING & PROMOTIONS STRATEGIES, BY TYPE
FIGURE 18 SURGICAL ROBOTS: INDUSTRY SPEAKS
FIGURE 19 REHABILITATION ROBOTS: INDUSTRY SPEAKS
FIGURE 20 NON-INVASIVE RADIOSURGICAL SYSTEMS (ROBOT-BASED): INDUSTRY SPEAKS
FIGURE 21 HOSPITAL & PHARMACY ROBOTS: INDUSTRY SPEAKS

プレスリリース

プレスリリース

Memo.png当レポートのプレスリリースは発行されておりません。

資料検索

お探しの資料・レポートをキーワードで検索ください。

当サイト内の検索結果が表示されます。調査レポートは英文目次を掲載しているため、英語検索も有効です。
(ブラウザのスクリプトを有効にしないとサーチエンジンが表示されません)

お問い合わせ

2714110_0.jpg
レポートをお探しいたします。
当サイトに掲載されているレポート以外にも幅広くご提案可能です。レポートの内容に関するご質問、ご確認にも回答いたします。お気軽にお問い合わせください。